Metabolism - Clinical and Experimental
Volume 53, Issue 10 , Pages 1336-1341 , October 2004

Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents

  • Naval K. Vikram

      Affiliations

    • Department of Medicine, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Anoop Misra

      Affiliations

    • Department of Medicine, All India Institute of Medical Sciences, New Delhi, India
    • Corresponding Author InformationAddress reprint requests to Anoop Misra, MD, Department of Internal Medicine, All India Institute of Medical Sciences, New Delhi 110029, India
    • ,
  • R.M. Pandey

      Affiliations

    • Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Manjari Dwivedi

      Affiliations

    • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Kalpana Luthra

      Affiliations

    • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India

Received 19 December 2003 ,Accepted 11 May 2004.

References 

  1. Kapil U, Singh P, Pathak P, et al.  Prevalence of obesity among affluent adolescent school children in Delhi. Indian Pediatr. 2002;39:449–452
  2. Guleria R, Dhingra V, Chatterjee A, et al.  Anthropometric profile in urban adolescents and young adults. J Assoc Physicians India. 2002;50:1521; abstr
  3. Arya S, Misra A, Vikram NK, et al.  Fasting hyperinsulinemia and its relationship to measures of obesity and lipid profile in urban adolescents and young adults in North India. Diabetes Metab. 2003;29(suppl, abstr):4S118, 4S119
  4. Steinberger J, Moran A, Hong CP, et al.  Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J Pediatr. 2001;138:469–473
  5. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood (The Bogalusa Heart Study). Diabetes. 2002;51:204–209
  6. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X (Contribution of adipocytokines adipocyte-derived bioactive substances). Ann NY Acad Sci. 1999;892:146–154
  7. Funahashi T, Nakamura T, Shimomura I, et al.  Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999;38:202–206
  8. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance—The emerging role of the adipocyte as an endocrine organ. N Engl J Med. 2001;345:1345–1346
  9. Weyer C, Funahashi T, Tanaka S, et al.  Hypoadiponectinemia in obesity and type 2 diabetes (Close association with insulin resistance and hyperinsulinemia). J Clin Endocrinol Metab. 2001;86:1930–1935
  10. Weiss R, Dufour S, Groszmann A, et al.  Low adiponectin levels in adolescent obesity (A marker of increased intramyocellular lipid accumulation). J Clin Endocrinol Metab. 2003;88:2014–2018
  11. Nemet D, Wang P, Funahashi T, et al.  Adipocytokines, body composition, and fitness in children. Pediatr Res. 2003;53:148–152
  12. Stefan N, Bunt JC, Salbe AD, et al.  Plasma adiponectin concentrations in children (Relationships with obesity and insulinemia). J Clin Endocrinol Metab. 2002;87:4652–4656
  13. Valsamakis G, Chetty R, McTernan PG, et al.  Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab. 2003;5:131–135
  14. Ridker PM. High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818
  15. Visser M, Bouter LM, McQuillan GM, et al.  Elevated C-reactive protein levels in overweight and obese adults. JAMA. 2000;282:2131–2135
  16. Vikram NK, Misra A, Dwivedi M, et al.  Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis. 2003;168:305–313
  17. Festa A, D’Agostino R, Howard G, et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome (The Insulin Resistance Atherosclerosis Study (IRAS)). Circulation. 2000;102:42–47
  18. Chambers JC, Eda S, Bassett P, et al.  C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European Whites. Circulation. 2001;104:145–150
  19. Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol. 2003;148:657–662
  20. Ouchi N, Kihara S, Funahashi T, et al.  Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671–674
  21. Lemeshow S, Stroh G. Sampling Techniques for Evaluating Health Parameters in Developing Countries. Washington, DC: National Academy Press; 1998;
  22. Dudeja V, Misra A, Pandey RM, et al.  Body mass index does not accurately predict overweight in Asian Indians in northern India. Br J Nutr. 2001;86:105–112
  23. Sung RY, Lau P, Yu CW, et al.  Measurement of body fat using leg-to-leg bioimpedance. Arch Dis Child. 2001;85:263–327
  24. Freidewald WT, Levy RT, Frederikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugation. Clin Chem. 1972;18:499–502
  25. Matthews DR, Hosker JP, Rudenski AS, et al.  Homeostasis model assessment (Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man). Diabetologia. 1985;28:412–419
  26. Tschritter O, Fritsche A, Thamer C, et al.  Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52:239–243
  27. Engeli S, Feldpausch M, Gorzelniak K, et al.  Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003;52:942–947

☆ Supported by a financial grant from the Department of Science and Technology, Ministry of Science and Technology, Government of India.

PII: S0026-0495(04)00241-0

doi: 10.1016/j.metabol.2004.05.010

Metabolism - Clinical and Experimental
Volume 53, Issue 10 , Pages 1336-1341 , October 2004

Article Tools

* Image Usage & Resolution